YOLFTbeta
Plasmapp Co., Ltd.

Plasmapp Co., Ltd.

405000 · KQ · Healthcare / Medical Devices

3,540.00KRW+45.00 (+1.29%)

Price History

Full chart

Market Stats

Previous Close3,495.00
Open3,495.00
Day Range3,410.00 – 3,600.00
52-Week Range3,030.00 – 9,400.00
Volume438
Market Cap13.86B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.01
50-Day Avg3,902.60
200-Day Avg5,508.70

About

Plasmapp Co., Ltd. develops, manufactures, and sells plasma sterilizers for medical tools. The company provides STERLINK sterilization system, a low-temperature plasma sterilization technology for medical operations; and instrument tracking systems, which is a real-time sterilization monitoring system. It also offers Actilink, a product lineup for plasma regenerative activator. The company was founded in 2015 and is based in Daejeon, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Youbong Lim
  • Headquarters111 Bio Venture Center, Daejeon, South Korea, Korea
  • Websitehttps://www.plasmapp.co.kr

Leadership

  • Mr. Youbong LimCEO & President · b. 1981
  • Yoo-dong HongManaging Director · b. 1976

Financials

Income Statement

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Revenue13.31B12.92B10.14B8.48B
Growth (%)--2.92%-21.51%-16.34%
Cost of Revenue12.80B11.66B11.23B6.62B
Gross Profit504.59M1.26B-1.09B1.87B
Gross Margin3.79%9.75%-10.72%22.02%
Operating Expense17.86B21.83B16.57B9.47B
Operating Income-17.35B-20.57B-17.66B-7.60B
Operating Margin-130.41%-159.26%-174.16%-89.60%
EBITDA-15.85B-14.92B-16.60B-3.75B
EBITDA Margin-119.11%-115.50%-163.73%-44.19%
Net Income-17.68B-18.79B-20.78B-6.59B
Net Income Margin-132.88%-145.48%-204.99%-77.65%
R&D5.24B6.04B4.42B3.26B
R&D as % of Total Revenue39.37%46.72%43.63%38.43%
Interest Expense741.30M2.10B2.41B1.53B
Interest Expense % of Total Revenue5.57%16.22%23.78%18.05%

Balance Sheet

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Total Assets36.25B39.78B25.51B20.55B
Total Liabilities26.88B31.70B20.99B14.83B
Total Equity9.37B8.08B4.53B5.72B
Cash4.97B7.37B2.65B3.87B
Net Debt13.43B10.45B11.18B5.30B

Cash Flow

Currency: KRW2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-16.00B-22.04B-11.09B-4.52B
Capital Expenditure12.12B1.96B609.59M279.39M
Free Cash Flow-28.12B-24.01B-11.70B-4.80B
FCF to OCF175.73%108.90%105.50%106.18%

Earnings

Report DateDec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------
EPS Actual-2969.79-3614.45-2312.13-1753.56-2369.32-1775.75-2852.59-2393.96-2148.37-1020.85-320.86-690.13-336.19-604.10-608.11
Surprise---------------
Timing---------------

Key Statistics & Ratios

Market Cap13.86B
Enterprise Value24.67B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.15
Price / Book10.85
Revenue (TTM)12.02B
Gross Profit (TTM)1.69B
EBITDA-5.96B
Profit Margin-64.31%
Operating Margin-80.37%
Return on Equity-154.60%
Return on Assets-22.07%
Shares Outstanding3.82M
Shares Float179.09K
Beta1.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Apr 11, 20250.1:1